CCL17 and asthma: [7]–[13]. Neutralization of CCL17 by treatment with antibody ameliorates the impacts of disease in both the A. fumigatus and ova models of asthma, and liver damage in the P. acnes mouse model of induced hepatic injury by blocking influx of T cells. [8], [10], [11].